Staar Surgical Stock Performance
| STAA Stock | USD 24.13 0.55 2.23% |
The entity owns a Beta (Systematic Risk) of 0.44, which indicates possible diversification benefits within a given portfolio. As returns on the market increase, STAAR Surgical's returns are expected to increase less than the market. However, during the bear market, the loss of holding STAAR Surgical is expected to be smaller as well. At this point, STAAR Surgical has a negative expected return of -0.16%. Please make sure to validate STAAR Surgical's skewness, day typical price, and the relationship between the maximum drawdown and daily balance of power , to decide if STAAR Surgical performance from the past will be repeated at future time.
Risk-Adjusted Performance
Weakest
Weak | Strong |
Over the last 90 days STAAR Surgical has generated negative risk-adjusted returns adding no value to investors with long positions. Despite latest uncertain performance, the Stock's basic indicators remain strong and the current disturbance on Wall Street may also be a sign of long term gains for the company investors. ...more
Actual Historical Performance (%)
One Day Return (2.15) | Five Day Return (5.44) | Year To Date Return 0.21 | Ten Year Return 219.02 | All Time Return 55.81 |
Last Split Factor 1:2 | Last Split Date 1992-05-18 |
1 | STAAR Surgical A Fresh Look at Valuation After Recent Share Price Pullback | 10/16/2025 |
2 | 1 Cash-Heavy Stock on Our Buy List and 2 Facing Challenges | 10/27/2025 |
3 | Broadwood continues pressure on STAAR board, urges new directors amid go-shop move | 11/10/2025 |
4 | Acquisition by Broadwood Partners, L.p. of tradable shares of STAAR Surgical subject to Rule 16b-3 | 11/20/2025 |
5 | Sangamo Therapeutics Announces FDA Acceptance of BLA Rolling Submission Request for ST-920 in Fabry Disease | 11/21/2025 |
6 | Broadwood Partners, L.P. Purchases 309,132 Shares of STAAR Surgical Stock | 11/26/2025 |
7 | Broadwood pushes for removal of 3 STAAR Surgical board members | 12/02/2025 |
8 | STAAR Surgical Valuation Check After Recent Share Price Rebound | 12/04/2025 |
9 | STAAR Surgical Shares Down 5.9 percent Whats Next | 12/08/2025 |
10 | What Makes Staar Surgical a New Buy Stock | 12/09/2025 |
11 | STAAR Surgical Company STAA Shares Sold by WINTON GROUP Ltd | 12/10/2025 |
12 | Why STAAR Surgical Stock Is Up Today | 12/11/2025 |
13 | Battle for STAAR Surgical intensifies as Glass Lewis reiterates stance against | 12/12/2025 |
| Begin Period Cash Flow | 183 M | |
| Total Cashflows From Investing Activities | -59.2 M |
STAAR Surgical Relative Risk vs. Return Landscape
If you would invest 2,767 in STAAR Surgical on September 15, 2025 and sell it today you would lose (354.00) from holding STAAR Surgical or give up 12.79% of portfolio value over 90 days. STAAR Surgical is currently does not generate positive expected returns and assumes 3.128% risk (volatility on return distribution) over the 90 days horizon. In different words, 28% of stocks are less volatile than STAAR, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
STAAR Surgical Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for STAAR Surgical's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as STAAR Surgical, and traders can use it to determine the average amount a STAAR Surgical's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = -0.0519
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | STAA |
Based on monthly moving average STAAR Surgical is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of STAAR Surgical by adding STAAR Surgical to a well-diversified portfolio.
STAAR Surgical Fundamentals Growth
STAAR Stock prices reflect investors' perceptions of the future prospects and financial health of STAAR Surgical, and STAAR Surgical fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on STAAR Stock performance.
| Return On Equity | -0.25 | ||||
| Return On Asset | -0.0788 | ||||
| Profit Margin | (0.42) % | ||||
| Operating Margin | 0.26 % | ||||
| Current Valuation | 1.04 B | ||||
| Shares Outstanding | 49.37 M | ||||
| Price To Earning | 460.83 X | ||||
| Price To Book | 3.37 X | ||||
| Price To Sales | 5.17 X | ||||
| Revenue | 313.9 M | ||||
| Gross Profit | 170.33 M | ||||
| EBITDA | (5.72 M) | ||||
| Net Income | (20.21 M) | ||||
| Cash And Equivalents | 202.49 M | ||||
| Cash Per Share | 4.22 X | ||||
| Total Debt | 38.74 M | ||||
| Debt To Equity | 0.10 % | ||||
| Current Ratio | 6.37 X | ||||
| Book Value Per Share | 7.17 X | ||||
| Cash Flow From Operations | 15.72 M | ||||
| Earnings Per Share | (1.96) X | ||||
| Market Capitalization | 1.19 B | ||||
| Total Asset | 509.52 M | ||||
| Retained Earnings | (67.58 M) | ||||
| Working Capital | 297.63 M | ||||
| Current Asset | 49.07 M | ||||
| Current Liabilities | 17.89 M | ||||
About STAAR Surgical Performance
By analyzing STAAR Surgical's fundamental ratios, stakeholders can gain valuable insights into STAAR Surgical's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if STAAR Surgical has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if STAAR Surgical has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
| Last Reported | Projected for Next Year | ||
| Days Of Inventory On Hand | 121.64 | 115.55 | |
| Return On Tangible Assets | 0.08 | 0.08 | |
| Return On Capital Employed | 0.11 | 0.12 | |
| Return On Assets | 0.08 | 0.08 | |
| Return On Equity | 0.11 | 0.11 |
Things to note about STAAR Surgical performance evaluation
Checking the ongoing alerts about STAAR Surgical for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for STAAR Surgical help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| STAAR Surgical generated a negative expected return over the last 90 days | |
| STAAR Surgical has high historical volatility and very poor performance | |
| The company reported the previous year's revenue of 313.9 M. Net Loss for the year was (20.21 M) with profit before overhead, payroll, taxes, and interest of 170.33 M. | |
| STAAR Surgical has a strong financial position based on the latest SEC filings | |
| Over 99.0% of the company shares are owned by institutional investors | |
| Latest headline from au.finance.yahoo.com: Battle for STAAR Surgical intensifies as Glass Lewis reiterates stance against |
- Analyzing STAAR Surgical's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether STAAR Surgical's stock is overvalued or undervalued compared to its peers.
- Examining STAAR Surgical's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating STAAR Surgical's management team can have a significant impact on its success or failure. Reviewing the track record and experience of STAAR Surgical's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of STAAR Surgical's stock. These opinions can provide insight into STAAR Surgical's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for STAAR Stock analysis
When running STAAR Surgical's price analysis, check to measure STAAR Surgical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy STAAR Surgical is operating at the current time. Most of STAAR Surgical's value examination focuses on studying past and present price action to predict the probability of STAAR Surgical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move STAAR Surgical's price. Additionally, you may evaluate how the addition of STAAR Surgical to your portfolios can decrease your overall portfolio volatility.
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes |